Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | CCNK | O75909 | 1/20 | 0.32 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12967131 | 1.00 | CA2 (0.54) | CA2ALDH1A1NPSR1CYP2D6SLC6A2 | |
| SCHEMBL1786903 | 1.00 | CA2 (0.54) | CA2ALDH1A1NPSR1CYP2D6SLC6A2 | |
| SCHEMBL7875753 | 0.90 | CA2 (0.59) | CA2ALDH1A1NPSR1TSHRMAPK1 | |
| SCHEMBL17461669 | 0.89 | CA2 (0.49) | CA2ALDH1A1NPSR1CYP2D6SLC6A2 | |
| SCHEMBL2462186 | 0.85 | CA2 (0.51) | CA2ALDH1A1NPSR1TSHRMAPK1 | |
| SCHEMBL1700171 | 0.84 | CA2 (0.54) | CA2ALDH1A1NPSR1TSHRMAPK1 | |
| SCHEMBL3428396 | 0.82 | CA2 (0.53) | CA2ALDH1A1NPSR1TSHRMAPK1 | |
| SCHEMBL12921173 | 0.82 | CA2 (0.53) | CA2ALDH1A1NPSR1TSHRMAPK1 | |
| SCHEMBL15928442 | 0.82 | SMN1; SMN2 (0.59) | CA2ALDH1A1NPSR1TSHRMAPK1 | |
| SCHEMBL15928604 | 0.82 | SMN1; SMN2 (0.59) | CA2ALDH1A1NPSR1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2825151-B1 | COMPOSITION | GIVAUDAN SA (CH) | 2021-04-07 | — | — | EP | claimed |
| US-9820927-B2 | Aqueous oil in water micro-emulsions, and product | GIVAUDAN SA (CH) | 2017-11-21 | — | — | US | claimed |
| CN-104379118-A | Composition | GIVAUDAN SA | 2015-02-25 | — | — | CN | claimed |
| EP-2825151-A2 | COMPOSITION | Givaudan SA (CH) | 2015-01-21 | — | — | EP | claimed |
| US-20140371128-A1 | Composition | GIVAUDAN SA (CH) | 2014-12-18 | — | — | US | claimed |
| WO-2013092962-A2 | COMPOSITION | GIVAUDAN SA (CH) | 2013-06-27 | — | — | WO | claimed |
| US-9820927-B2 | Aqueous oil in water micro-emulsions, and product | GIVAUDAN SA (CH) | 2017-11-21 | — | — | US | disclosed |
| US-20170081266-A1 | AROMATIC COMPOUNDS BEARING HYDROXYL-SUBSTITUTED (PER)FLUOROPOLYETHER CHAINS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2017-03-23 | — | — | US | disclosed |
| WO-2015173374-A1 | AROMATIC COMPOUNDS BEARING HYDROXYL-SUBSTITUTED (PER)FLUOROPOLYETHER CHAINS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2015-11-19 | — | — | WO | disclosed |
| US-20150113860-A1 | FUEL COMPOSITIONS COMPRISING HYDROPHOBIC DERIVATIVES OF GLYCERINE | ENI S.P.A. (IT) | 2015-04-30 | — | — | US | disclosed |
| US-20140371128-A1 | Composition | GIVAUDAN SA (CH) | 2014-12-18 | — | — | US | disclosed |
| EP-1809624-B1 | PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2013-11-20 | — | — | EP | disclosed |
| US-8519019-B2 | Non-shrinking; consists of concentrated silica solution comprising colloidal amorphous silica particles in at least one continuous silicon phase and a photosensitizer | BLUESTAR SILICONES FRANCE SAS (FR) | 2013-08-27 | — | — | US | disclosed |
| EP-1809624-A1 | PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2007-07-25 | — | — | EP | disclosed |
| US-7247660-B2 | Dental composition based on silicone crosslinkable by cation process | RHODIA CHIMIE (FR) | 2007-07-24 | — | — | US | disclosed |
| US-7247660-B2 | Dental composition based on silicone crosslinkable by cation process | RHODIA CHIMIE (FR) | 2007-07-24 | — | — | US | disclosed |
| US-20070149636-A1 | Dental composition based on silicone crosslinkable by cation process | FRANCES JEAN-MARC | 2007-06-28 | — | — | US | disclosed |
| US-20070149636-A1 | Dental composition based on silicone crosslinkable by cation process | FRANCES JEAN-MARC | 2007-06-28 | — | — | US | disclosed |
| WO-2006024823-A9 | PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2007-03-15 | — | — | WO | disclosed |
| WO-2006024823-A1 | PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2006-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170081266-A1 | AROMATIC COMPOUNDS BEARING HYDROXYL-SUBSTITUTED (PER)FLUOROPOLYETHER CHAINS | SRMS, AHR, C9 | CA2 4865/4885ALDH1A1 106/4885NPSR1 2877/4885 |
| US-20140371128-A1 | Composition | CUTA, C5, DEGS1 | CA2 3334/4885ALDH1A1 888/4885NPSR1 1759/4885 |
| US-20150113860-A1 | FUEL COMPOSITIONS COMPRISING HYDROPHOBIC DERIVATIVES OF GLYCERINE | GK, GRK5, DGKG | CA2 3397/4885ALDH1A1 1805/4885NPSR1 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.